Rx (Prescription Medicine)
USD $ 120.00
Myzomib 2mg 注射剂是一种含有活性成分 Bortezomib 的药物。Bortezomib 是一种蛋白酶抑制剂，通过阻断细胞内蛋白酶体的活性发挥作用。蛋白酶体是分解不需要或受损蛋白质的蛋白质复合体。通过抑制蛋白酶体，Bortezomib 可导致癌细胞中异常蛋白的积累，从而引发细胞死亡。该机制使其在治疗某些类型的癌症方面具有效性。Myzomib 2mg 注射剂主要用于治疗多发性骨髓瘤和套细胞淋巴瘤。剂量和给药方式应严格遵医嘱，依据患者的病情和反应进行调整。常见的不良反应可能包括疲劳、腹泻、便秘、恶心、呕吐以及周围神经病变。患者应向医生报告任何严重或持续的不良反应。本药应储存在室温，避光防潮，并置于儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
其他品牌的 Bortezomib 2 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
